Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
LH.US
id: 983, Created by , Scout

Labcorp (LH) Inaccurate Prenatal Tests Case

  • In January 2022, the NYT article questioned the accuracy of certain prenatal tests offered by Labcorp (LH).
  • On it, $LH fell 5%, losing $1.36B+ of shareholder value.
  • Investors may have grounds to suspect that Labcorp runs inadequate quality control of its tests’ operation, which led to thier losses.
On January 1, 2022, NYT article questioned the accuracy of certain prenatal tests, alleging that:
  • positive test results on tests are about 85 percent incorrect,
  • positive results require expensive follow-up testing with a small risk of miscarriage, that can’t be performed until later in pregnancy.
On this news, $LH fell 5% and lost over $1.36 billion of its market capitalization, seriously damaging shareholders.

Considering all the information, investors might have grounds to suspect that Labcorp failed to timely disclose the Company’s quality control setbacks, which consequently led to their losses.

The case is already under investigation by at least one of the reputable law firms.
Alleged Offence
Misleading Statements
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
03 January 2022
Collecting participants…

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make c...

    Ticker
    LH.US
    ISIN
    US50540R4092
    CIK
    920148
    Sector
    Healthcare
    Industry
    Diagnostics & Research
    Country
    USA
    Address
    358 South Main Street, Burlington, NC, United States, 27215